CAMP4 Therapeutics (CAMP)
4.25
-0.09 (2.07%)
Upcoming Events
Latest Headlines
Camp4 Therapeutics gets UK approval for SYNGAP1 drug trial
September 10, 2026 7:33 AM - StreetInsider
CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder
September 10, 2026 7:33 AM - Globe NewsWire
CAMP4 Therapeutics to Host Virtual Analyst Day to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder on September 28, 2026
September 8, 2026 4:05 PM - StreetInsider
CAMP4 to Participate in Upcoming Investor Conferences
September 1, 2026 4:05 PM - StreetInsider
Form 4 Camp4 Therapeutics Corp For: Aug 24 Filed by: Schwab Andrew J.
August 26, 2026 4:58 PM - SEC Filing
Form 4 Camp4 Therapeutics Corp For: Aug 19 Filed by: Schwab Andrew J.
August 21, 2026 4:59 PM - SEC Filing
Form 4 Camp4 Therapeutics Corp For: Aug 19 Filed by: Tardiff Daniel
August 19, 2026 8:46 PM - SEC Filing
CAMP4 Therapeutics Corp (CAMP) PT Raised to $15 at Piper Sandler
August 14, 2026 8:26 AM - StreetInsider
Calamp Corp. (CAMP) Misses Q2 EPS by 33c
August 14, 2026 5:51 AM - StreetInsider
CAMP4 Reports Second Quarter 2026 Financial Results and Corporate Highlights
August 13, 2026 4:05 PM - StreetInsider
Form 4 Camp4 Therapeutics Corp For: Aug 03 Filed by: 5AM Ventures VII, L.P.
August 5, 2026 5:40 PM - SEC Filing
Form 4 Camp4 Therapeutics Corp For: Aug 03 Filed by: Schwab Andrew J.
August 5, 2026 5:29 PM - SEC Filing
Form 4 Camp4 Therapeutics Corp For: Aug 03 Filed by: Young Richard A
August 5, 2026 5:10 PM - SEC Filing
Form 4 Camp4 Therapeutics Corp For: Aug 03 Filed by: Maricich Yuri
August 5, 2026 5:09 PM - SEC Filing
Form 4 Camp4 Therapeutics Corp For: Aug 03 Filed by: Gold Kelly
August 5, 2026 5:08 PM - SEC Filing
Form 4 Camp4 Therapeutics Corp For: Aug 03 Filed by: Mandel-Brehm Josh
August 5, 2026 5:07 PM - SEC Filing
Camp4 Therapeutics closes second tranche of $100M private placement
August 4, 2026 7:00 AM - StreetInsider
CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement
August 4, 2026 7:00 AM - StreetInsider
Camp4 Therapeutics gets Australian clearance for SYNGAP1 drug trial
July 27, 2026 7:02 AM - StreetInsider
CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder
July 27, 2026 7:00 AM - StreetInsider
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 17, 2026 4:05 PM - StreetInsider
X4 Pharmaceuticals adds Kelly Gold to its board of directors
July 1, 2026 7:00 AM - StreetInsider
X4 Pharmaceuticals Appoints Kelly Gold, Experienced Chief Financial Officer, to its Board of Directors
July 1, 2026 7:00 AM - Globe NewsWire
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 19, 2026 4:05 PM - StreetInsider
JPMorgan Upgrades CAMP4 Therapeutics Corp (CAMP) to Overweight
June 16, 2026 12:37 AM - StreetInsider
Full Article List
